Have a feature idea you'd love to see implemented? Let us know!

EPIX Essa Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: EPIX

Price (delayed)

$1.76

Market cap

$78.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.62

Enterprise value

-$7.81M

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in ...

Highlights
The company's debt fell by 3.3% QoQ
EPIX's quick ratio is down by 18% year-on-year but it is up by 12% since the previous quarter
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://essapharma.com
Peers: OLMA OMER OMGA ONCT

Key stats

What are the main financial stats of EPIX
Market
Shares outstanding
44.37M
Market cap
$78.09M
Enterprise value
-$7.81M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.61
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$27.67M
EBITDA
-$27.57M
Free cash flow
-$23.84M
Per share
EPS
-$0.62
Free cash flow per share
-$0.54
Book value per share
$2.9
Revenue per share
$0
TBVPS
$2.99
Balance sheet
Total assets
$132.67M
Total liabilities
$3.8M
Debt
$342,142
Equity
$128.86M
Working capital
$128.52M
Liquidity
Debt to equity
0
Current ratio
36.95
Quick ratio
36.68
Net debt/EBITDA
3.12
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-19.6%
Return on equity
-20.2%
Return on invested capital
-36.5%
Return on capital employed
-21.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EPIX stock price

How has the Essa Pharma stock price performed over time
Intraday
1.73%
1 week
0%
1 month
-70.76%
1 year
-69.71%
YTD
-73.33%
QTD
-70.96%

Financial performance

How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.88M
Net income
-$27.67M
Gross margin
N/A
Net margin
N/A
EPIX's operating income is down by 6% year-on-year

Growth

What is Essa Pharma's growth rate over time

Valuation

What is Essa Pharma stock price valuation
P/E
N/A
P/B
0.61
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The stock's price to book (P/B) is 73% less than its 5-year quarterly average of 2.3 and 68% less than its last 4 quarters average of 1.9
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Essa Pharma business performance
EPIX's return on invested capital is down by 48% year-on-year and by 22% since the previous quarter
EPIX's ROE is down by 17% YoY and by 3.6% from the previous quarter
EPIX's return on assets is down by 15% year-on-year and by 3.2% since the previous quarter

Dividends

What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EPIX.

Financial health

How did Essa Pharma financials performed over time
The company's current ratio fell by 18% YoY but it rose by 12% QoQ
EPIX's quick ratio is down by 18% year-on-year but it is up by 12% since the previous quarter
The company's debt is 100% lower than its equity
EPIX's equity is down by 14% year-on-year and by 3.5% since the previous quarter
The company's debt fell by 3.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.